Fanconi syndrome associated with cidofovir therapy
Author:
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/AAC.41.8.1846
Reference5 articles.
1. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine against human cytomegalovirus when administered as single-bolus dose and continuous infusion in in vitro cell culture perfusion system;Moore M. R.;Antimicrob. Agents Chemother.,1994
2. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria;Polis M. A.;Antimicrob. Agents Chemother.,1995
3. Evaluation of infrequent dosing regimens with (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl-cytosine (S-HPMPC) on simian varicella infection in monkeys;Soike K. F.;Antivir. Res.,1991
4. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo;Stals E. S.;Antimicrob. Agents Chemother.,1991
5. Indinavir nephropathy;Tashima K. T.;N. Engl. J. Med.,1997
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy;Transplant Infectious Disease;2024-09-03
2. Renal Fanconi Syndromes and Other Proximal Tubular Disorders;Pediatric Kidney Disease;2023
3. Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study;Journal of Antimicrobial Chemotherapy;2021-07-29
4. Transplant Adenovirus Infection: Clinical Syndromes, Diagnosis, and Management;Emerging Transplant Infections;2021
5. Transplant Adenovirus Infection: Clinical Syndromes, Diagnosis, and Management;Emerging Transplant Infections;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3